Vascular damage: A persisting pathology common to Alzheimer's disease and traumatic brain injury

Medical Hypotheses

Volumn 81, Issue 5, 2013, Pages 842-845

  Franzblau, Max ^a   Gonzales Portillo, Chiara ^a   Gonzales Portillo, Gabriel S ^a   Diamandis, Theo ^a   Borlongan, Mia C ^a   Tajiri, Naoki ^a   Borlongan, Cesar V ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; BLOOD VESSEL INJURY; BRAIN BLOOD VESSEL; BRAIN DEGENERATION; HIPPOCAMPUS; HUMAN; NONHUMAN; TRAUMATIC BRAIN INJURY;

MUS;

ALZHEIMER DISEASE; ANIMALS; BLOOD VESSELS; BLOOD-BRAIN BARRIER; BRAIN; BRAIN INJURIES; HUMANS; MICE; MODELS, BIOLOGICAL;

EID: 84886804524     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2013.09.012     Document Type: Article

References (51)

1. Shlosberg D., Benifla M., Kaufer D., Friedman A. Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury. Nat Rev Neurol 2010, 6:393-403.
2. Borlongan C.V. Recent preclinical evidence advancing cell therapy for Alzheimer's disease. Exp Neurol 2012, 237:142-146.
3. Bartus R., Dean R.L., Beer B., Lippa A.S. The cholinergic hypothesis of geriatric memory dysfunction. Science 1982, 217:408-411.
4. Coyle J.T., Price D.L., DeLong M.R. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 1983, 219:1184-1190.
5. Whitehouse P.J., Price D.L., Clark A.W., Coyle J.T., DeLong M.R. Alzheimer dis- ease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 1981, 10:122-126.
6. Verdile G., Fuller S., Atwood C.S., Laws S.M., Gandy S.E., Martins R.N. The role of beta amyloid in Alzheimer's disease: still a cause of everything or the only one who got caught?. Pharmacol Res 2004, 50:397-409.
7. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
8. Stanimirovic D.B., Friedman A. Pathophysiology of the neurovascular unit: disease cause or consequence?. J Cereb Blood Flow Metab 2012, 32:1207-1221.
9. Zlokovic B.V. Neurodegeneration and the neurovascular unit. Nat Med 2010, 16:1370-1371.
10. Iadecola C., Hachinski V., Rosenberg G.A. Vascular cognitive impairment: introduction. Stroke 2010, 41:S127-S 128.
11. Corrigan J.D., Selassie A.W., Orman J.A. The epidemiology of traumatic brain injury. J Head Trauma Rehabil 2010, 25:72-80.
12. Selassie A.W., Zaloshnja E., Langlois J.A., Miller T., Jones P., Steiner C. Incidence of long-term disability following traumatic brain injury hospitalization in the United States. J Head Trauma Rehabil 2008, 23:123-131.
13. Hernandez-Ontiveros D.G., Tajiri N., Acosta S., Giunta B., Tan J., Borlongan C.V. Microglia activation as a biomarker for traumatic brain injury. Front Neurol 2013, 4:30.
14. Bogdanova Y., Verfaellie M. Cognitive sequelae of blast-induced traumatic brain injury: recovery and rehabilitation. Neuropsychol Rev 2012, 22:4-20.
15. Duckworth J.L., Grimes J., Ling G.S. Pathophysiology of battlefield associated traumatic brain injury. Pathophysiology 2012, 10.1016/j.pathophys.2012.03.001.
16. Goeller J., Wardlaw A., Treichler D., O'Bruba J., Weiss G. Investigation of cavitation as a possible damage mechanism in blast-induced traumatic brain injury. J Neurotrauma 2012, 29:1970-1981.
17. Andriessen T.M., Jacobs B., Vos P.E. Clinical characteristics and pathophysiological mechanisms of focal and diffuse traumatic brain injury. J Cell Mol Med 2010, 14:2381-2392.
18. Sahuquillo J., Poca M.A., Amoros S. Current aspects of pathophysiology and cell dysfunction after severe head injury. Curr Pharm Des 2001, 7(1475):1503.
19. Tompkins P., Tesiram Y., Lerner M., Gonzalez L.P., Lightfoot S.A., Raab C.H., et al. Brain injury: neuro-inflammation, cognitive deficit & MRI in a model of blast-induced TBI. J Neurotrauma 2013, 10.1089/neu.2012.2674.
20. Morganti-Kossmann M.C., Rancan M., Otto V.I., Stahel P.F., Kossman T. Role of cerebral inflammation after traumatic brain injury: a revised concept. Shock 2001, 16:165-177.
21. Shojo H., Kaneko Y., Mabuchi T., Kibayashi K., Adachi N., Borlongan C.V. Genetic and histological evidence implicates role of inflammation in traumatic brain injury-induced apoptosis in the rat cerebral cortex following moderate fluid percussion injury. Neuroscience 2010, 171:1273-1282.
22. McKeating E.G., Andrews P.J., Macia L. Leukocyte adhesion molecule profiles and outcome after traumatic brain injury. Acta Neurochir Suppl 1998, 71:200-202.
23. Tompkins O., Shelef I., Kaizerman I., Eliushin A., Afawi Z., Misk A., et al. Blood-brain barrier disruption in post-traumatic epilepsy. J Neurol Neurosurg Psychiatry 2008, 79:774-777.
24. Nag S., Kapadia A., Stewart D.J. Review: molecular pathogenesis of blood-brain barrier breakdown in acute brain injury. Neuropathol Appl Neurobiol 2011, 37:3-23.
25. Nag S., Venugopalan R., Stewart D.J. Increased caveolin-1 expression precedes decreased expression of occludin and claudin-5 during blood-brain barrier breakdown. Acta Neuropathol 2007, 114:459-469.
26. Nag S., Manias J.L., Stewart D.J. Expression of endothelial phosphorylated caveolin-1 is increased in brain injury. Neuropathol Appl Neurobiol 2009, 35:417-426.
27. Zhao J., Moore A.N., Redell J.B., Dash P.K. Enhancing expression of Nrf2-driven genes protects the blood brain barrier after brain injury. J Neurosci 2007, 27:10240-10248.
28. Yeung D., Manias J.L., Stewart D.J., Nag S. Decreased junctional adhesion molecule-a expression during blood-brain barrier breakdown. Acta Neuropathol 2008, 115:635-642.
29. Infante-Duarte C., Waiczies S., Wuerfel J., Zipp F. New developments in understanding and treating neuroinflammation. J Mol Med 2008, 86:975-985.
30. Oby E., Janigro D. The blood-brain barrier and epilepsy. Epilepsia 2006, 47:1761-1774.
31. Skaper S.D. The brain as a target for inflammatory processes and neuroprotective strategies. Ann NY Acad Sci 2007, 1122:23-34.
32. Guo Z., Cupples L.A., Kurz A., Auerbach S.H., Volicer L., Chui H., et al. Head injury and the risk of AD in the MIRAGE study. Neurology 2000, 54:1316-1323.
33. Jellinger K., Paulus W., Wrocklage C., Litvan I. Traumatic brain injury as a risk factor for Alzheimer disease. Comparison of two retrospective autopsy cohorts with evaluation of ApoE genotype. BMC Neurol 2001, 1:3.
34. Cirrito J.R., Kang J.E., Lee J., Stewart F.R., Verges D.K., Silverio L.M., et al. Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo. Neuron 2008, 58:42-51.
35. Meyer-Luehmann M., Spires-Jones T.L., Prada C., Garcia-Alloza M., de Calignon A., Rozkalne A., et al. Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer's disease. Nature 2008, 451:720-724.
36. DeKosky S.T., Ikonomovic M.D., Gandy S. Traumatic brain injury: football, warfare, and long-term effects. N Engl J Med 2010, 363:1293-1296.
37. Miller G. A battle no soldier wants to fight. Science 2011, 333:517.
38. Tajiri N., Glover L.E., Shimizu T., Arendash G.W., Borlongan C.V. Traumatic brain injury expedites the presentation of Alzheimer's disease-like histopathology in transgenic mice. Int Conf Alzheimer's Drug Discovery 2011, 12:12.
39. Davies T.A., Long H.J., Eisenhauer P.B., Hastey R., Cribbs D.H., Fine R.E., et al. Beta amyloid fragments derived from activated platelets deposit in cerebrovascular endothelium: usage of a novel blood brain barrier endothelial cell model system. Amyloid 2000, 7:153-165.
40. Mlekusch R., Humpel C. Matrix metalloproteinases-2 and -3 are reduced in cerebrospinal fluid with low beta-amyloid1-42 levels. Neurosci Lett 2009, 466:135-138.
41. Palmer J.C., Kehoe P.G., Love S. Endothelin-converting enzyme-1 in Alzheimer's disease and vascular dementia. Neuropathol Appl Neurobiol 2010, 36:487-497.
42. Aliev G., Seyidova D., Lamb B.T., Obrenovich M.E., Siedlak S.L., Vinters H.V., et al. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice. Neurol Res 2003, 25:665-674.
43. Jantaratnotai N., Ryu J.K., Schwab C., McGeer P.L., McLarnon J.G. Comparison of Vascular Perturbations in an Abeta-Injected Animal Model and in AD Brain. Int J Alzheimers Dis 2011, 10.4061/2011/918280.
44. Borroni B., Akkawi N., Martini G., Colciaghi F., Prometti P., Rozzini L., et al. Microvascular damage and platelet abnormalities in early Alzheimer's disease. J Neurol Sci 2002, 203-204:189-193.
45. Walker D.G., Dalsing-Hernandez J.E., Lue L.F. Human postmortem brain-derived cerebrovascular smooth muscle cells express all genes of the classical complement pathway: a potential mechanism for vascular damage in cerebral amyloid angiopathy and Alzheimer's disease. Microvasc Res 2008, 75:411-419.
46. Yesil Y., Kuyumcu M.E., Cankurtaran M., Uz B., Kara A., Kilic M.K., et al. Increased mean platelet volume (MPV) indicating the vascular risk in Alzheimer's disease (AD). Arch Gerontol Geriatr 2011, 55:257-260.
47. Pettus E.H., Wright D.W., Stein D.G., Hoffman S.W. Progesterone treatment inhibits the inflammatory agents that accompany traumatic brain injury. Brain Res 2005, 1049:112-119.
48. You Z., Yang J., Takahashi K., Yager P.H., Kim H.H., Qin T., et al. Reduced tissue damage and improved recovery of motor function after traumatic brain injury in mice deficient in complement component C4. J Cereb Blood Flow Metab 2007, 27:1954-1964.
49. Kellogg S.L., Tajiri N., Shimizu T., Arendash G.W., Borlongan C.V. Behavioral and histological effects of traumatic brain injury on Alzheimer's disease transgenic mice. Soc Neurosci Abstr 2011, 561:20.
50. Tran H.T., LaFerla F.M., Holtzman D.M., Brody D.L. Controlled cortical impact traumatic brain injury in 3xTg-AD mice causes acute intra-axonal amyloid-β accumulation and independently accelerates the development of tau abnormalities. J Neurosci 2011, 31:9513-9925.
51. Arendash G.W., Mori T., Dorsey M., Gonzalez R., Tajiri N., Borlongan C. Electromagnetic treatment to old Alzheimer's mice reverses β-amyloid deposition, modifies cerebral blood flow, and provides selected cognitive benefit. PLoS One 2012, 7:e35751.